Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
Roberto Gallego-Pinazo1,2, Ana Marina Suelves-Cogollos1, Ester Francés-Muñoz1, J María Millán2,3, J Fernando Arevalo4, J Luis Mullor5, Manuel Díaz-Llopis1,2,61Department of Ophthalmology, Hospital Universitario La Fe, Valenci...
Enregistré dans:
Auteurs principaux: | Roberto Gallego-Pinazo, Ana Marina Suelves-Cogollos, Ester Francés-Muñoz, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ce457d695cbe4dd0b47a38f5a27108df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Single intravitreal ranibizumab for myopic choroidal neovascularization
par: Shatriah I, et autres
Publié: (2011) -
Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
par: Ellabban AA, et autres
Publié: (2012) -
Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
par: Yamashita M, et autres
Publié: (2014) -
Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome
par: Luis Arias, et autres
Publié: (2010) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
par: Karagiannis D, et autres
Publié: (2017)